Active immunization of pregnant individuals at 32 through 36 wk gestational age for prevention of lower resp tract disease (LRTD) & severe LRTD caused by RSV in infants from birth through 6 mth. Active immunization for LRTD prevention in individuals ≥60 yr.
Appropriate medical treatment must be immediately available in the event an anaphylactic reaction occurs following administration. Potential risk of preterm birth. Syncope may occur; place procedures to avoid injury from fainting. Immunocompromised individuals including those receiving immunosuppressive therapy may have diminished immune response to Abrysvo. May not protect all vaccine recipients. Pregnant individuals <24 wk gestational age & those at increased risk of preterm birth. Lactation. Non-pregnant individuals <18 yr. Childn <10 yr.
J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.
Sign Out
